PMID- 14622908 OWN - NLM STAT- MEDLINE DCOM- 20040217 LR - 20220321 IS - 0306-4522 (Print) IS - 0306-4522 (Linking) VI - 122 IP - 3 DP - 2003 TI - Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity. PG - 647-57 AB - This study was designed to identify molecular mechanisms by which exercise affects synaptic-plasticity in the hippocampus, a brain area whose function, learning and memory, depends on this capability. We have focused on the central role that brain-derived neurotrophic factor (BDNF) may play in mediating the effects of exercise on synaptic-plasticity. In fact, this impact of exercise is exemplified by our finding that BDNF regulates the mRNA levels of two end products important for neural function, i.e. cAMP-response-element binding (CREB) protein and synapsin I. CREB and synapsin I have the ability to modify neuronal function by regulating gene-transcription and affecting synaptic transmission, respectively. Furthermore, we show that BDNF is capable of concurrently increasing the mRNA levels of both itself and its tyrosine kinaseB (TrkB) receptor, suggesting that exercise may employ a feedback loop to augment the effects of BDNF on synaptic-plasticity. The use of a novel microbead injection method in our blocking experiments and Taqman reverse transcription polymerase reaction (RT-PCR) for RNA quantification, have enabled us to evaluate the contribution of different pathways to the exercise-induced increases in the mRNA levels of BDNF, TrkB, CREB, and synapsin I. We found that although BDNF mediates exercise-induced hippocampal plasticity, additional molecules, i.e. the N-methyl-D-aspartate receptor, calcium/calmodulin protein kinase II and the mitogen-activated protein kinase cascade, modulate its effects. Since these molecules have a well-described association to BDNF action, our results illustrate a basic mechanism through which exercise may promote synaptic-plasticity in the adult brain. FAU - Vaynman, S AU - Vaynman S AD - Department of Physiological Science, UCLA, 621 Charles E. Young Drive, Los Angeles, CA 90095, USA. FAU - Ying, Z AU - Ying Z FAU - Gomez-Pinilla, F AU - Gomez-Pinilla F LA - eng GR - NS 38978/NS/NINDS NIH HHS/United States GR - NS 39522/NS/NINDS NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Enzyme Inhibitors) RN - 0 (Neuroprotective Agents) RN - 0 (Neurotrophin 3) RN - 0 (Proteins) RN - 0 (RNA, Messenger) RN - 0 (Synapsins) RN - 0 (protein phosphatase inhibitor-2) RN - 6LR8C1B66Q (Dizocilpine Maleate) RN - EC 2.7.10.1 (Receptor, trkB) SB - IM MH - Analysis of Variance MH - Animals MH - Behavior, Animal MH - Brain-Derived Neurotrophic Factor/genetics/*metabolism MH - Cyclic AMP Response Element-Binding Protein/genetics/metabolism MH - Dizocilpine Maleate/pharmacology MH - Enzyme Inhibitors/pharmacology MH - Hippocampus/cytology/drug effects MH - Male MH - Microspheres MH - Models, Biological MH - Neuronal Plasticity/drug effects/*physiology MH - Neuroprotective Agents/pharmacology MH - Neurotrophin 3/genetics/metabolism MH - Physical Conditioning, Animal/*physiology MH - Proteins/*metabolism MH - RNA, Messenger/biosynthesis MH - Random Allocation MH - Rats MH - Rats, Sprague-Dawley MH - Receptor, trkB/genetics/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction/methods MH - Signal Transduction/drug effects/genetics/*physiology MH - Synapsins/genetics/metabolism MH - Time Factors EDAT- 2003/11/19 05:00 MHDA- 2004/02/18 05:00 CRDT- 2003/11/19 05:00 PHST- 2003/11/19 05:00 [pubmed] PHST- 2004/02/18 05:00 [medline] PHST- 2003/11/19 05:00 [entrez] AID - S0306452203006109 [pii] AID - 10.1016/j.neuroscience.2003.08.001 [doi] PST - ppublish SO - Neuroscience. 2003;122(3):647-57. doi: 10.1016/j.neuroscience.2003.08.001.